As noted on February 14, 2013, Baker Bros Advisors LLC's purchase was done indirectly through "See Footnotes" over 6 transactions from February 13, 2013 to February 14, 2013. The share price ranged from $28.43 to $28.58 according to the regulatory filing detailing the transactions.
If we look over the past 12 months, Baker Bros Advisors LLC has sold no shares of Genomic Health Inc stock. Over the same time period, Baker Bros Advisors LLC has purchased 52,000 shares of Genomic Health Inc, with a total cost of $1,480,987.
Let's take a quick, high-level look at insider trading at Genomic Health Inc over the past 12 months. A total of 406,140 shares of Genomic Health Inc stock was sold by insiders, totaling $12,756,974. Over the same time 12 month time period, 3,252,221 shares of Genomic Health Inc, for a total value of $95,214,362 were purchased by company insiders.
To view the complete SEC Filing: Genomic Health Inc Form 4 (Insider Trading) SEC Filing
